Article Details

Sierra Oncology (NASDAQ:SRRA) Rating Lowered to Sell at Zacks Investment Research

Retrieved on: 2021-03-18 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (NASDAQ:SRRA) Rating Lowered to Sell at Zacks Investment Research. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 106,774 shares of the biotechnology company's stock valued at $1,712,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up